免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Cellvizio 100系列共聚焦激光成像系统和它们的共聚焦微探头

K号: K183640 · 2019-02-22

决定日期2019-02-22
产品代码OWN
咨询委员会GU 请注意,由于您只提供了“GU”这个词,我无法提供完整的翻译。如果您能提供完整的句子或段落,我将能够为您提供准确的翻译。
决定实质等同

器械摘要

Cellvizio 100 Series Confocal laser Imaging systems and their Confocal Miniprobes is the device name listed in this FDA 510(k) record. The listed applicant is Mauna Kea Technologies. It received FDA 510(k) clearance on 2019-02-22 under 510(k) number K183640. The device is classified under product code OWN. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Cellvizio 100 Series Confocal laser Imaging systems and their Confocal Miniprobes?

Cellvizio 100 Series Confocal laser Imaging systems and their Confocal Miniprobes is a medical device that received FDA 510(k) clearance on 2019-02-22. The listed applicant is Mauna Kea Technologies. The 510(k) number is K183640.

When did Cellvizio 100 Series Confocal laser Imaging systems and their Confocal Miniprobes receive FDA 510(k) clearance?

Cellvizio 100 Series Confocal laser Imaging systems and their Confocal Miniprobes received FDA 510(k) clearance on 2019-02-22, under 510(k) number K183640.

Who is the listed applicant for Cellvizio 100 Series Confocal laser Imaging systems and their Confocal Miniprobes?

The FDA 510(k) record lists Mauna Kea Technologies as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Cellvizio 100 Series Confocal laser Imaging systems and their Confocal Miniprobes?

The FDA product code for Cellvizio 100 Series Confocal laser Imaging systems and their Confocal Miniprobes is OWN.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Mauna Kea Technologies为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

查看所有 9 个设备 →

相关器械(代码:OWN)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑